In vivo experiments in osteosarcoma xenograft models showed that miR-193a-5p targets NCX2; NCX2 knockdown activates AKT by increasing Ca2+, thus promoting epithelial-mesenchymal transition (EMT) and enhancing metastasis to the lung and liver (44). Here, SLC8A2 is linked to osteosarcoma.